Inventor · Wayland, MA, US

Kallanthottathil G. Rajeev

192Patents
29h-index
88Co-inventors
93Inventor score

Filing activity: Aug 10, 2004 → Oct 8, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US8158601B2 Lipid formulation Emerging Cross-Sectional Technologies 293 Active
US9345780B2 Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic components Chemistry; Metallurgy 237 Active
US8106022B2 Carbohydrate conjugates as delivery agents for oligonucleotides Emerging Cross-Sectional Technologies 229 Active
US8828956B2 Carbohydrate conjugates as delivery agents for oligonucleotides Emerging Cross-Sectional Technologies 160 Active
US8450467B2 Carbohydrate conjugates as delivery agents for oligonucleotides Emerging Cross-Sectional Technologies 145 Active
US8642076B2 Lipid containing formulations Human Necessities 138 Active
US7723509B2 IRNA agents with biocleavable tethers Chemistry; Metallurgy 118 Active
US7582744B2 Chemically modified oligonucleotides Chemistry; Metallurgy 117 Expired
US8802644B2 Lipid formulation Emerging Cross-Sectional Technologies 110 Active
US9394234B2 Lipid formulations Emerging Cross-Sectional Technologies 99 Active
US9352048B2 Carbohydrate conjugates as delivery agents for oligonucleotides Emerging Cross-Sectional Technologies 99 Active
US8883202B2 Lipid compositions Emerging Cross-Sectional Technologies 95 Active
US9012498B2 Biodegradable lipids for the delivery of active agents Chemistry; Metallurgy 94 Active
US8999351B2 Lipids and compositions for the delivery of therapeutics Emerging Cross-Sectional Technologies 91 Active
US9290760B2 Modified iRNA agents Chemistry; Metallurgy 90 Active
US9186325B2 Lipids and compositions for the delivery of therapeutics Emerging Cross-Sectional Technologies 89 Active
US9796974B2 Modified RNAi agents Chemistry; Metallurgy 85 Active
US7745608B2 Modified iRNA agents Chemistry; Metallurgy 79 Expired
US8575123B2 Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components Chemistry; Metallurgy 52 Active
US8344125B2 Modified iRNA agents Chemistry; Metallurgy 51 Active
US8927513B2 5′ phosphate mimics Chemistry; Metallurgy 45 Active
US8034376B2 Lipid containing formulations Human Necessities 41 Active
US8404862B2 Ligand-conjugated monomers Chemistry; Metallurgy 39 Active
US8722082B2 Lipids and compositions for the delivery of therapeutics Chemistry; Metallurgy 37 Active
US8809516B2 Therapeutic compositions Chemistry; Metallurgy 36 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.